ISPE Names CEO

The International Society for Pharmaceutical Engineering (ISPE) has named Nancy S. Berg as president and chief executive officer. She replaces Bob Best, who resigned after a 27-year career with the Society. Mr. Best will remain involved in the organization as a consultant through the end of 2012.

Ms. Berg has 30 years of experience in strategic leadership, having served as executive director/chief executive officer of the Society of Manufacturing Engineers (SME) and as the founder and owner of three small businesses and a consultant to both non-profits and for-profits.

At SME, Ms. Berg led the development of a strategic plan and the expansion of technical networks. She was named executive director in 2000, making her the youngest person to head a global engineering/technical organization at the time. Prior to that, she held other domestic and international positions where she facilitated dialog, joint ventures and coalitions with other trade groups, associations, companies, governments and agencies.

“Berg’s demonstrated ability to anticipate industry changes, set a vision for success, then lead coordinated, dynamic efforts to achieve this plan make her the ideal person to drive us in achieving our mission,” said 2012 ISPE chairman Arthur “Randy” Perez. “Berg’s appointment comes at a time when the global pharmaceutical industry faces increased pressure to improve productivity and control costs across their product development and manufacturing operations. She brings the right blend of knowledge and leadership experience to guide us in enhancing our value to our Members, our relevance to the industry, and our role as a catalyst for solutions that will positively influence global health.”